Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 367 entries
Sorted by: Best Match Show Resources per page
Identification of an Alternative rRNA Post-transcriptional Maturation of 26S rRNA in the Kingdom Fungi.

Frontiers in microbiology

Navarro-Ródenas A, Carra A, Morte A.
PMID: 29887836
Front Microbiol. 2018 May 25;9:994. doi: 10.3389/fmicb.2018.00994. eCollection 2018.

Despite of the integrity of their RNA, some desert truffles present a non-canonical profile of rRNA where 3.3 kb is absent, 1.8 kb is clear and a band of 1.6 kb is observed. A similar rRNA profile was identified...

Cite
Navarro-Ródenas A, Carra A, Morte A. Identification of an Alternative rRNA Post-transcriptional Maturation of 26S rRNA in the Kingdom Fungi. Front Microbiol. 2018;9:994doi: 10.3389/fmicb.2018.00994.
Navarro-Ródenas, A., Carra, A., & Morte, A. (2018). Identification of an Alternative rRNA Post-transcriptional Maturation of 26S rRNA in the Kingdom Fungi. Frontiers in microbiology, 9994. https://doi.org/10.3389/fmicb.2018.00994
Navarro-Ródenas, Alfonso, et al. "Identification of an Alternative rRNA Post-transcriptional Maturation of 26S rRNA in the Kingdom Fungi." Frontiers in microbiology vol. 9 (2018): 994. doi: https://doi.org/10.3389/fmicb.2018.00994
Navarro-Ródenas A, Carra A, Morte A. Identification of an Alternative rRNA Post-transcriptional Maturation of 26S rRNA in the Kingdom Fungi. Front Microbiol. 2018 May 25;9:994. doi: 10.3389/fmicb.2018.00994. eCollection 2018. PMID: 29887836; PMCID: PMC5981135.
Copy Download .nbib Format: NLM
Genomic Characterization of Listeria monocytogenes Isolates Associated with Clinical Listeriosis and the Food Production Environment in Ireland.

Genes

Hilliard A, Leong D, O'Callaghan A, Culligan EP, Morgan CA, DeLappe N, Hill C, Jordan K, Cormican M, Gahan CGM.
PMID: 29558450
Genes (Basel). 2018 Mar 20;9(3). doi: 10.3390/genes9030171.

No abstract available.

Cite
Hilliard A, Leong D, O'Callaghan A, et al. Genomic Characterization of Listeria monocytogenes Isolates Associated with Clinical Listeriosis and the Food Production Environment in Ireland. Genes (Basel). 2018;9(3)doi: 10.3390/genes9030171.
Hilliard, A., Leong, D., O'Callaghan, A., Culligan, E. P., Morgan, C. A., DeLappe, N., Hill, C., Jordan, K., Cormican, M., & Gahan, C. G. M. (2018). Genomic Characterization of Listeria monocytogenes Isolates Associated with Clinical Listeriosis and the Food Production Environment in Ireland. Genes, 9(3), . https://doi.org/10.3390/genes9030171
Hilliard, Amber, et al. "Genomic Characterization of Listeria monocytogenes Isolates Associated with Clinical Listeriosis and the Food Production Environment in Ireland." Genes vol. 9,3 (2018). doi: https://doi.org/10.3390/genes9030171
Hilliard A, Leong D, O'Callaghan A, Culligan EP, Morgan CA, DeLappe N, Hill C, Jordan K, Cormican M, Gahan CGM. Genomic Characterization of Listeria monocytogenes Isolates Associated with Clinical Listeriosis and the Food Production Environment in Ireland. Genes (Basel). 2018 Mar 20;9(3). doi: 10.3390/genes9030171. PMID: 29558450; PMCID: PMC5867892.
Copy Download .nbib Format: NLM
Enhanced Control and Reproducibility of Non-Neutral Plasmas.

Physical review letters

Ahmadi M, Alves BXR, Baker CJ, Bertsche W, Capra A, Carruth C, Cesar CL, Charlton M, Cohen S, Collister R, Eriksson S, Evans A, Evetts N, Fajans J, Friesen T, Fujiwara MC, Gill DR, Hangst JS, Hardy WN, Hayden ME, Isaac CA, Johnson MA, Jones SA, Jonsell S, Kurchaninov L, Madsen N, Mathers M, Maxwell D, McKenna JTK, Menary S, Momose T, Munich JJ, Olchanski K, Olin A, Pusa P, Rasmussen CØ, Robicheaux F, Sacramento RL, Sameed M, Sarid E, Silveira DM, So C, Stutter G, Tharp TD, Thompson JE, Thompson RI, van der Werf DP, Wurtele JS.
PMID: 29376718
Phys Rev Lett. 2018 Jan 12;120(2):025001. doi: 10.1103/PhysRevLett.120.025001.

The simultaneous control of the density and particle number of non-neutral plasmas confined in Penning-Malmberg traps is demonstrated. Control is achieved by setting the plasma's density by applying a rotating electric field while simultaneously fixing its axial potential via...

Cite
Ahmadi M, Alves BXR, Baker CJ, et al. Enhanced Control and Reproducibility of Non-Neutral Plasmas. Phys Rev Lett. 2018;120(2):025001doi: 10.1103/PhysRevLett.120.025001.
Ahmadi, M., Alves, B. X. R., Baker, C. J., Bertsche, W., Capra, A., Carruth, C., Cesar, C. L., Charlton, M., Cohen, S., Collister, R., Eriksson, S., Evans, A., Evetts, N., Fajans, J., Friesen, T., Fujiwara, M. C., Gill, D. R., Hangst, J. S., Hardy, W. N., Hayden, M. E., Isaac, C. A., Johnson, M. A., Jones, S. A., Jonsell, S., Kurchaninov, L., Madsen, N., Mathers, M., Maxwell, D., McKenna, J. T. K., Menary, S., Momose, T., Munich, J. J., Olchanski, K., Olin, A., Pusa, P., Rasmussen, C. �. �., Robicheaux, F., Sacramento, R. L., Sameed, M., Sarid, E., Silveira, D. M., So, C., Stutter, G., Tharp, T. D., Thompson, J. E., Thompson, R. I., van der Werf, D. P., Wurtele, J. S. (2018). Enhanced Control and Reproducibility of Non-Neutral Plasmas. Physical review letters, 120(2), 025001. https://doi.org/10.1103/PhysRevLett.120.025001
Ahmadi, M, et al. "Enhanced Control and Reproducibility of Non-Neutral Plasmas." Physical review letters vol. 120,2 (2018): 025001. doi: https://doi.org/10.1103/PhysRevLett.120.025001
Ahmadi M, Alves BXR, Baker CJ, Bertsche W, Capra A, Carruth C, Cesar CL, Charlton M, Cohen S, Collister R, Eriksson S, Evans A, Evetts N, Fajans J, Friesen T, Fujiwara MC, Gill DR, Hangst JS, Hardy WN, Hayden ME, Isaac CA, Johnson MA, Jones SA, Jonsell S, Kurchaninov L, Madsen N, Mathers M, Maxwell D, McKenna JTK, Menary S, Momose T, Munich JJ, Olchanski K, Olin A, Pusa P, Rasmussen CØ, Robicheaux F, Sacramento RL, Sameed M, Sarid E, Silveira DM, So C, Stutter G, Tharp TD, Thompson JE, Thompson RI, van der Werf DP, Wurtele JS. Enhanced Control and Reproducibility of Non-Neutral Plasmas. Phys Rev Lett. 2018 Jan 12;120(2):025001. doi: 10.1103/PhysRevLett.120.025001. PMID: 29376718.
Copy Download .nbib Format: NLM
First Generation Amperometric Biosensing of Galactose with Xerogel-Carbon Nanotube Layer-By-Layer Assemblies.

Nanomaterials (Basel, Switzerland)

Labban N, Wayu MB, Steele CM, Munoz TS, Pollock JA, Case WS, Leopold MC.
PMID: 30597967
Nanomaterials (Basel). 2018 Dec 29;9(1). doi: 10.3390/nano9010042.

A first-generation amperometric galactose biosensor has been systematically developed utilizing layer-by-layer (LbL) construction of xerogels, polymers, and carbon nanotubes toward a greater fundamental understanding of sensor design with these materials and the potential development of a more efficient galactosemia...

Cite
Labban N, Wayu MB, Steele CM, et al. First Generation Amperometric Biosensing of Galactose with Xerogel-Carbon Nanotube Layer-By-Layer Assemblies. Nanomaterials (Basel). 2018;9(1)doi: 10.3390/nano9010042.
Labban, N., Wayu, M. B., Steele, C. M., Munoz, T. S., Pollock, J. A., Case, W. S., & Leopold, M. C. (2018). First Generation Amperometric Biosensing of Galactose with Xerogel-Carbon Nanotube Layer-By-Layer Assemblies. Nanomaterials (Basel, Switzerland), 9(1), . https://doi.org/10.3390/nano9010042
Labban, Najwa, et al. "First Generation Amperometric Biosensing of Galactose with Xerogel-Carbon Nanotube Layer-By-Layer Assemblies." Nanomaterials (Basel, Switzerland) vol. 9,1 (2018). doi: https://doi.org/10.3390/nano9010042
Labban N, Wayu MB, Steele CM, Munoz TS, Pollock JA, Case WS, Leopold MC. First Generation Amperometric Biosensing of Galactose with Xerogel-Carbon Nanotube Layer-By-Layer Assemblies. Nanomaterials (Basel). 2018 Dec 29;9(1). doi: 10.3390/nano9010042. PMID: 30597967; PMCID: PMC6359589.
Copy Download .nbib Format: NLM
Observation of the 1S-2P Lyman-α transition in antihydrogen.

Nature

Ahmadi M, Alves BXR, Baker CJ, Bertsche W, Capra A, Carruth C, Cesar CL, Charlton M, Cohen S, Collister R, Eriksson S, Evans A, Evetts N, Fajans J, Friesen T, Fujiwara MC, Gill DR, Hangst JS, Hardy WN, Hayden ME, Hunter ED, Isaac CA, Johnson MA, Jones JM, Jones SA, Jonsell S, Khramov A, Knapp P, Kurchaninov L, Madsen N, Maxwell D, McKenna JTK, Menary S, Michan JM, Momose T, Munich JJ, Olchanski K, Olin A, Pusa P, Rasmussen CØ, Robicheaux F, Sacramento RL, Sameed M, Sarid E, Silveira DM, Starko DM, Stutter G, So C, Tharp TD, Thompson RI, van der Werf DP, Wurtele JS.
PMID: 30135588
Nature. 2018 Sep;561(7722):211-215. doi: 10.1038/s41586-018-0435-1. Epub 2018 Aug 22.

In 1906, Theodore Lyman discovered his eponymous series of transitions in the extreme-ultraviolet region of the atomic hydrogen spectrum

Cite
Ahmadi M, Alves BXR, Baker CJ, et al. Observation of the 1S-2P Lyman-α transition in antihydrogen. Nature. 2018;561(7722):211-215doi: 10.1038/s41586-018-0435-1.
Ahmadi, M., Alves, B. X. R., Baker, C. J., Bertsche, W., Capra, A., Carruth, C., Cesar, C. L., Charlton, M., Cohen, S., Collister, R., Eriksson, S., Evans, A., Evetts, N., Fajans, J., Friesen, T., Fujiwara, M. C., Gill, D. R., Hangst, J. S., Hardy, W. N., Hayden, M. E., Hunter, E. D., Isaac, C. A., Johnson, M. A., Jones, J. M., Jones, S. A., Jonsell, S., Khramov, A., Knapp, P., Kurchaninov, L., Madsen, N., Maxwell, D., McKenna, J. T. K., Menary, S., Michan, J. M., Momose, T., Munich, J. J., Olchanski, K., Olin, A., Pusa, P., Rasmussen, C. �. �., Robicheaux, F., Sacramento, R. L., Sameed, M., Sarid, E., Silveira, D. M., Starko, D. M., Stutter, G., So, C., Tharp, T. D., Thompson, R. I., van der Werf, D. P., & Wurtele, J. S. (2018). Observation of the 1S-2P Lyman-α transition in antihydrogen. Nature, 561(7722), 211-215. https://doi.org/10.1038/s41586-018-0435-1
Ahmadi, M, et al. "Observation of the 1S-2P Lyman-α transition in antihydrogen." Nature vol. 561,7722 (2018): 211-215. doi: https://doi.org/10.1038/s41586-018-0435-1
Ahmadi M, Alves BXR, Baker CJ, Bertsche W, Capra A, Carruth C, Cesar CL, Charlton M, Cohen S, Collister R, Eriksson S, Evans A, Evetts N, Fajans J, Friesen T, Fujiwara MC, Gill DR, Hangst JS, Hardy WN, Hayden ME, Hunter ED, Isaac CA, Johnson MA, Jones JM, Jones SA, Jonsell S, Khramov A, Knapp P, Kurchaninov L, Madsen N, Maxwell D, McKenna JTK, Menary S, Michan JM, Momose T, Munich JJ, Olchanski K, Olin A, Pusa P, Rasmussen CØ, Robicheaux F, Sacramento RL, Sameed M, Sarid E, Silveira DM, Starko DM, Stutter G, So C, Tharp TD, Thompson RI, van der Werf DP, Wurtele JS. Observation of the 1S-2P Lyman-α transition in antihydrogen. Nature. 2018 Sep;561(7722):211-215. doi: 10.1038/s41586-018-0435-1. Epub 2018 Aug 22. PMID: 30135588; PMCID: PMC6786973.
Copy Download .nbib Format: NLM
CRISPR/Cas9-mediated SARM1 knockout and epitope-tagged mice reveal that SARM1 does not regulate nuclear transcription, but is expressed in macrophages.

The Journal of biological chemistry

Doran CG, Sugisawa R, Carty M, Roche F, Fergus C, Hokamp K, Kelly VP, Bowie AG.
PMID: 34793837
J Biol Chem. 2021 Nov 16;297(6):101417. doi: 10.1016/j.jbc.2021.101417. Epub 2021 Nov 16.

SARM1 is a toll/interleukin-1 receptor -domain containing protein, with roles proposed in both innate immunity and neuronal degeneration. Murine SARM1 has been reported to regulate the transcription of chemokines in both neurons and macrophages; however, the extent to which...

Cite
Doran CG, Sugisawa R, Carty M, et al. CRISPR/Cas9-mediated SARM1 knockout and epitope-tagged mice reveal that SARM1 does not regulate nuclear transcription, but is expressed in macrophages. J Biol Chem. 2021;297(6):101417doi: 10.1016/j.jbc.2021.101417.
Doran, C. G., Sugisawa, R., Carty, M., Roche, F., Fergus, C., Hokamp, K., Kelly, V. P., & Bowie, A. G. (2021). CRISPR/Cas9-mediated SARM1 knockout and epitope-tagged mice reveal that SARM1 does not regulate nuclear transcription, but is expressed in macrophages. The Journal of biological chemistry, 297(6), 101417. https://doi.org/10.1016/j.jbc.2021.101417
Doran, Ciara G, et al. "CRISPR/Cas9-mediated SARM1 knockout and epitope-tagged mice reveal that SARM1 does not regulate nuclear transcription, but is expressed in macrophages." The Journal of biological chemistry vol. 297,6 (2021): 101417. doi: https://doi.org/10.1016/j.jbc.2021.101417
Doran CG, Sugisawa R, Carty M, Roche F, Fergus C, Hokamp K, Kelly VP, Bowie AG. CRISPR/Cas9-mediated SARM1 knockout and epitope-tagged mice reveal that SARM1 does not regulate nuclear transcription, but is expressed in macrophages. J Biol Chem. 2021 Nov 16;297(6):101417. doi: 10.1016/j.jbc.2021.101417. Epub 2021 Nov 16. PMID: 34793837.
Copy Download .nbib Format: NLM
Analysis of autoantibody spectrum and human herpesvirus 6 in adult patients with 'early' versus 'late' diagnosis of 'possible limbic encephalitis'.

Epilepsy research

Reimers A, Hummel CA, Eis-Hübinger AM, Surges R, Niehusmann P, Schoch S, Becker AJ, Pitsch J.
PMID: 34246119
Epilepsy Res. 2021 Oct;176:106698. doi: 10.1016/j.eplepsyres.2021.106698. Epub 2021 Jun 23.

New onset temporal seizures are increasingly encountered in adult patients. Many of those fulfill diagnostic criteria for possible or definite limbic encephalitis (LE). LE is associated with autoantibodies (autoABs) against neuronal surface structures ('neuronal' autoABs), 'onconeuronal' or GAD65. AutoABs...

Cite
Reimers A, Hummel CA, Eis-Hübinger AM, et al. Analysis of autoantibody spectrum and human herpesvirus 6 in adult patients with 'early' versus 'late' diagnosis of 'possible limbic encephalitis'. Epilepsy Res. 2021;176:106698doi: 10.1016/j.eplepsyres.2021.106698.
Reimers, A., Hummel, C. A., Eis-Hübinger, A. M., Surges, R., Niehusmann, P., Schoch, S., Becker, A. J., & Pitsch, J. (2021). Analysis of autoantibody spectrum and human herpesvirus 6 in adult patients with 'early' versus 'late' diagnosis of 'possible limbic encephalitis'. Epilepsy research, 176106698. https://doi.org/10.1016/j.eplepsyres.2021.106698
Reimers, Annika, et al. "Analysis of autoantibody spectrum and human herpesvirus 6 in adult patients with 'early' versus 'late' diagnosis of 'possible limbic encephalitis'." Epilepsy research vol. 176 (2021): 106698. doi: https://doi.org/10.1016/j.eplepsyres.2021.106698
Reimers A, Hummel CA, Eis-Hübinger AM, Surges R, Niehusmann P, Schoch S, Becker AJ, Pitsch J. Analysis of autoantibody spectrum and human herpesvirus 6 in adult patients with 'early' versus 'late' diagnosis of 'possible limbic encephalitis'. Epilepsy Res. 2021 Oct;176:106698. doi: 10.1016/j.eplepsyres.2021.106698. Epub 2021 Jun 23. PMID: 34246119.
Copy Download .nbib Format: NLM
Modified Cephalic Index Measured at Superior Levels of the Cranium Revealed Improved Correction With Helmet Therapy for Patients With Sagittal Suture Craniosynostosis.

The Journal of craniofacial surgery

Abernethy LM, England DL, Price CA, Stevens PM, Wurdeman SR.
PMID: 34387265
J Craniofac Surg. 2021 Aug 13; doi: 10.1097/SCS.0000000000008070. Epub 2021 Aug 13.

OBJECTIVE: Historically, studies have shown that cranial remolding therapy improves surgical correction and protects against regression for patients with sagittal suture craniosynostosis. This study aimed to define the most responsive cranial height for measuring cephalic index (CI) following cranial...

Cite
Abernethy LM, England DL, Price CA, et al. Modified Cephalic Index Measured at Superior Levels of the Cranium Revealed Improved Correction With Helmet Therapy for Patients With Sagittal Suture Craniosynostosis. J Craniofac Surg. 2021;doi: 10.1097/SCS.0000000000008070.
Abernethy, L. M., England, D. L., Price, C. A., Stevens, P. M., & Wurdeman, S. R. (2021). Modified Cephalic Index Measured at Superior Levels of the Cranium Revealed Improved Correction With Helmet Therapy for Patients With Sagittal Suture Craniosynostosis. The Journal of craniofacial surgery, . https://doi.org/10.1097/SCS.0000000000008070
Abernethy, Lisa M, et al. "Modified Cephalic Index Measured at Superior Levels of the Cranium Revealed Improved Correction With Helmet Therapy for Patients With Sagittal Suture Craniosynostosis." The Journal of craniofacial surgery vol. (2021). doi: https://doi.org/10.1097/SCS.0000000000008070
Abernethy LM, England DL, Price CA, Stevens PM, Wurdeman SR. Modified Cephalic Index Measured at Superior Levels of the Cranium Revealed Improved Correction With Helmet Therapy for Patients With Sagittal Suture Craniosynostosis. J Craniofac Surg. 2021 Aug 13; doi: 10.1097/SCS.0000000000008070. Epub 2021 Aug 13. PMID: 34387265.
Copy Download .nbib Format: NLM
Combination of ferrocene decorated gold nanoparticles and engineered primers for the direct reagentless determination of isothermally amplified DNA.

Mikrochimica acta

Al-Madhagi S, O'Sullivan CK, Prodromidis MI, Katakis I.
PMID: 33687553
Mikrochim Acta. 2021 Mar 09;188(4):117. doi: 10.1007/s00604-021-04771-8.

A reagent-less DNA sensor has been developed exploiting a combination of gold nanoparticles, modified primers, and isothermal amplification. It is applied to the determination ofKarlodinium armiger, a toxic microalgae, as a model analyte to demonstrate this generic platform. Colloidal...

Cite
Al-Madhagi S, O'Sullivan CK, Prodromidis MI, et al. Combination of ferrocene decorated gold nanoparticles and engineered primers for the direct reagentless determination of isothermally amplified DNA. Mikrochim Acta. 2021;188(4):117doi: 10.1007/s00604-021-04771-8.
Al-Madhagi, S., O'Sullivan, C. K., Prodromidis, M. I., & Katakis, I. (2021). Combination of ferrocene decorated gold nanoparticles and engineered primers for the direct reagentless determination of isothermally amplified DNA. Mikrochimica acta, 188(4), 117. https://doi.org/10.1007/s00604-021-04771-8
Al-Madhagi, Sallam, et al. "Combination of ferrocene decorated gold nanoparticles and engineered primers for the direct reagentless determination of isothermally amplified DNA." Mikrochimica acta vol. 188,4 (2021): 117. doi: https://doi.org/10.1007/s00604-021-04771-8
Al-Madhagi S, O'Sullivan CK, Prodromidis MI, Katakis I. Combination of ferrocene decorated gold nanoparticles and engineered primers for the direct reagentless determination of isothermally amplified DNA. Mikrochim Acta. 2021 Mar 09;188(4):117. doi: 10.1007/s00604-021-04771-8. PMID: 33687553.
Copy Download .nbib Format: NLM
Laser cooling of antihydrogen atoms.

Nature

Baker CJ, Bertsche W, Capra A, Carruth C, Cesar CL, Charlton M, Christensen A, Collister R, Mathad AC, Eriksson S, Evans A, Evetts N, Fajans J, Friesen T, Fujiwara MC, Gill DR, Grandemange P, Granum P, Hangst JS, Hardy WN, Hayden ME, Hodgkinson D, Hunter E, Isaac CA, Johnson MA, Jones JM, Jones SA, Jonsell S, Khramov A, Knapp P, Kurchaninov L, Madsen N, Maxwell D, McKenna JTK, Menary S, Michan JM, Momose T, Mullan PS, Munich JJ, Olchanski K, Olin A, Peszka J, Powell A, Pusa P, Rasmussen CØ, Robicheaux F, Sacramento RL, Sameed M, Sarid E, Silveira DM, Starko DM, So C, Stutter G, Tharp TD, Thibeault A, Thompson RI, van der Werf DP, Wurtele JS.
PMID: 33790445
Nature. 2021 Apr;592(7852):35-42. doi: 10.1038/s41586-021-03289-6. Epub 2021 Mar 31.

The photon-the quantum excitation of the electromagnetic field-is massless but carries momentum. A photon can therefore exert a force on an object upon collision

Cite
Baker CJ, Bertsche W, Capra A, et al. Laser cooling of antihydrogen atoms. Nature. 2021;592(7852):35-42doi: 10.1038/s41586-021-03289-6.
Baker, C. J., Bertsche, W., Capra, A., Carruth, C., Cesar, C. L., Charlton, M., Christensen, A., Collister, R., Mathad, A. C., Eriksson, S., Evans, A., Evetts, N., Fajans, J., Friesen, T., Fujiwara, M. C., Gill, D. R., Grandemange, P., Granum, P., Hangst, J. S., Hardy, W. N., Hayden, M. E., Hodgkinson, D., Hunter, E., Isaac, C. A., Johnson, M. A., Jones, J. M., Jones, S. A., Jonsell, S., Khramov, A., Knapp, P., Kurchaninov, L., Madsen, N., Maxwell, D., McKenna, J. T. K., Menary, S., Michan, J. M., Momose, T., Mullan, P. S., Munich, J. J., Olchanski, K., Olin, A., Peszka, J., Powell, A., Pusa, P., Rasmussen, C. �. �., Robicheaux, F., Sacramento, R. L., Sameed, M., Sarid, E., Silveira, D. M., Starko, D. M., So, C., Stutter, G., Tharp, T. D., Thibeault, A., Thompson, R. I., van der Werf, D. P., & Wurtele, J. S. (2021). Laser cooling of antihydrogen atoms. Nature, 592(7852), 35-42. https://doi.org/10.1038/s41586-021-03289-6
Baker, C J, et al. "Laser cooling of antihydrogen atoms." Nature vol. 592,7852 (2021): 35-42. doi: https://doi.org/10.1038/s41586-021-03289-6
Baker CJ, Bertsche W, Capra A, Carruth C, Cesar CL, Charlton M, Christensen A, Collister R, Mathad AC, Eriksson S, Evans A, Evetts N, Fajans J, Friesen T, Fujiwara MC, Gill DR, Grandemange P, Granum P, Hangst JS, Hardy WN, Hayden ME, Hodgkinson D, Hunter E, Isaac CA, Johnson MA, Jones JM, Jones SA, Jonsell S, Khramov A, Knapp P, Kurchaninov L, Madsen N, Maxwell D, McKenna JTK, Menary S, Michan JM, Momose T, Mullan PS, Munich JJ, Olchanski K, Olin A, Peszka J, Powell A, Pusa P, Rasmussen CØ, Robicheaux F, Sacramento RL, Sameed M, Sarid E, Silveira DM, Starko DM, So C, Stutter G, Tharp TD, Thibeault A, Thompson RI, van der Werf DP, Wurtele JS. Laser cooling of antihydrogen atoms. Nature. 2021 Apr;592(7852):35-42. doi: 10.1038/s41586-021-03289-6. Epub 2021 Mar 31. PMID: 33790445; PMCID: PMC8012212.
Copy Download .nbib Format: NLM
Surgical Decompression for Cervical Spondylotic Myelopathy in Patients with Associated Hypertension: A Single-Center Retrospective Cohort and Systematic Review of the Literature.

World neurosurgery

Perdomo-Pantoja A, Chara A, Liu A, Jin Y, Taylor M, El Demerdash N, Ahmed AK, Pennington Z, Cottrill E, Westbroek EM, Bydon A, Theodore N, Witham TF.
PMID: 34400323
World Neurosurg. 2021 Nov;155:e119-e130. doi: 10.1016/j.wneu.2021.08.038. Epub 2021 Aug 13.

OBJECTIVE: To explore the relationship between spinal cord compression and hypertension through analysis of blood pressure (BP) variations in a cervical spondylotic myelopathy (CSM) cohort after surgical decompression, along with a review of the literature.METHODS: A single-institution retrospective review...

Cite
Perdomo-Pantoja A, Chara A, Liu A, et al. Surgical Decompression for Cervical Spondylotic Myelopathy in Patients with Associated Hypertension: A Single-Center Retrospective Cohort and Systematic Review of the Literature. World Neurosurg. 2021;155:e119-e130doi: 10.1016/j.wneu.2021.08.038.
Perdomo-Pantoja, A., Chara, A., Liu, A., Jin, Y., Taylor, M., El Demerdash, N., Ahmed, A. K., Pennington, Z., Cottrill, E., Westbroek, E. M., Bydon, A., Theodore, N., & Witham, T. F. (2021). Surgical Decompression for Cervical Spondylotic Myelopathy in Patients with Associated Hypertension: A Single-Center Retrospective Cohort and Systematic Review of the Literature. World neurosurgery, 155e119-e130. https://doi.org/10.1016/j.wneu.2021.08.038
Perdomo-Pantoja, Alexander, et al. "Surgical Decompression for Cervical Spondylotic Myelopathy in Patients with Associated Hypertension: A Single-Center Retrospective Cohort and Systematic Review of the Literature." World neurosurgery vol. 155 (2021): e119-e130. doi: https://doi.org/10.1016/j.wneu.2021.08.038
Perdomo-Pantoja A, Chara A, Liu A, Jin Y, Taylor M, El Demerdash N, Ahmed AK, Pennington Z, Cottrill E, Westbroek EM, Bydon A, Theodore N, Witham TF. Surgical Decompression for Cervical Spondylotic Myelopathy in Patients with Associated Hypertension: A Single-Center Retrospective Cohort and Systematic Review of the Literature. World Neurosurg. 2021 Nov;155:e119-e130. doi: 10.1016/j.wneu.2021.08.038. Epub 2021 Aug 13. PMID: 34400323.
Copy Download .nbib Format: NLM
Alliance A011801 (compassHER2 RD): postneoadjuvant T-DM1 + tucatinib/placebo in patients with residual HER2-positive invasive breast cancer.

Future oncology (London, England)

O'Sullivan CC, Ballman KV, McCall L, Kommalapati A, Zemla T, Weiss A, Mitchell M, Blinder V, Tung NM, Irvin WJ, Lee M, Goetz MP, Symmans WF, Borges VF, Krop I, Carey LA, Partridge AH.
PMID: 34636255
Future Oncol. 2021 Dec;17(34):4665-4676. doi: 10.2217/fon-2021-0753. Epub 2021 Oct 12.

This report describes the rationale, purpose and design of A011801 (CompassHER2 RD), an ongoing prospective, multicenter, Phase III randomized trial. Eligible patients in the United States (US) and Canada with high-risk (defined as ER-negative and/or node-positive) HER2-positive (HER2+) residual...

Cite
O'Sullivan CC, Ballman KV, McCall L, et al. Alliance A011801 (compassHER2 RD): postneoadjuvant T-DM1 + tucatinib/placebo in patients with residual HER2-positive invasive breast cancer. Future Oncol. 2021;17(34):4665-4676doi: 10.2217/fon-2021-0753.
O'Sullivan, C. C., Ballman, K. V., McCall, L., Kommalapati, A., Zemla, T., Weiss, A., Mitchell, M., Blinder, V., Tung, N. M., Irvin, W. J., Lee, M., Goetz, M. P., Symmans, W. F., Borges, V. F., Krop, I., Carey, L. A., & Partridge, A. H. (2021). Alliance A011801 (compassHER2 RD): postneoadjuvant T-DM1 + tucatinib/placebo in patients with residual HER2-positive invasive breast cancer. Future oncology (London, England), 17(34), 4665-4676. https://doi.org/10.2217/fon-2021-0753
O'Sullivan, Ciara C, et al. "Alliance A011801 (compassHER2 RD): postneoadjuvant T-DM1 + tucatinib/placebo in patients with residual HER2-positive invasive breast cancer." Future oncology (London, England) vol. 17,34 (2021): 4665-4676. doi: https://doi.org/10.2217/fon-2021-0753
O'Sullivan CC, Ballman KV, McCall L, Kommalapati A, Zemla T, Weiss A, Mitchell M, Blinder V, Tung NM, Irvin WJ, Lee M, Goetz MP, Symmans WF, Borges VF, Krop I, Carey LA, Partridge AH. Alliance A011801 (compassHER2 RD): postneoadjuvant T-DM1 + tucatinib/placebo in patients with residual HER2-positive invasive breast cancer. Future Oncol. 2021 Dec;17(34):4665-4676. doi: 10.2217/fon-2021-0753. Epub 2021 Oct 12. PMID: 34636255; PMCID: PMC8600597.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 367 entries